ClinicalTrials.gg
Drug

Contrast agent BR1 clinical trials

A product of Sulfur Hexafluoride; its studies count on that page too.

studies test it
14
open now
3
in phase 3
8
first study started
2009

How each study uses contrast agent BR1 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the contrast agent BR1 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Oct 2014 · LUMASON · NDA 203684 (FDA, Drugs@FDA; as Sulfur Hexafluoride)
European Union
26 Mar 2001 · SonoVue · EMEA/H/C/000303 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

SonoVue
10
sulfur hexafluoride microbubbles
3

Studies by the year they started

14 studies that test it; most in 2009 (2)

Studies that test contrast agent BR1, by start year
YearStudies
20092
20101
20112
20121
20141
20161
20172
20191
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 3
8
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 10

Bracco Diagnostics, Inc (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Enrico Ammirati (1) · Société Française d'Endoscopie Digestive (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · NaviFUS Corporation (1) · Central Hospital, Nancy, France (1) · Umeå University (1)

Often tested with

Tested in the same studies.

Iodixanol (1) · Sonazoid (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test contrast agent BR1, phase 3 first.

Studies

Open first, then newest update. How each study uses contrast agent BR1 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Given beside what is tested · 2 — contrast agent BR1 is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with contrast agent BR1

Codes

What other systems call contrast agent BR1 · ClinicalTrials.gg INT004309

  • MeSH (NLM) C420843contrast agent BR1One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.